Lexaria Bioscience Corp. Common Stock
$0.6406
USD
Last updated on --.
24h volume51.45K
24h highest0.67200 USD
24h lowest0.63800 USD
24h Price movement+0.57%
LEXX recent prices
24 Hours
+0.57%+$0.0036
30 days
+5.05%+$0.0308
60 days
-32.94%-$0.3146
90 days
-12.19%-$0.0889
Key data
Previous close0.63700 USD
Market cap14.92M USD
Volume51.45K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.38000 USD
Net income (FY)-9.54M USD
Revenue (FY)368.00K USD
Last report dateApr 13, 2026
About Lexaria Bioscience Corp. Common Stock
HeadquartersKELOWNA
Employees (FY)7.00
Revenue per employee (FY)52.57K USD
Net income per employee (FY)-1.36M USD
Listed onNasdaq
LEXX conversion tables
 |  |
|---|---|
| 0.5 LEXX | 0.3203 USD |
| 1 LEXX | 0.6406 USD |
| 5 LEXX | 3.203 USD |
| 10 LEXX | 6.406 USD |
| |
|---|---|
| 0.5 USD | 0.78052 LEXX |
| 1 USD | 1.561 LEXX |
| 5 USD | 7.805 LEXX |
| 10 USD | 15.61 LEXX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LEXX is trading at $0.6406, +0.57% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LEXX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LEXX is currently trading at $0.6406, +0.57% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LEXX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LEXX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LEXX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LEXX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lexaria Bioscience Corp. Common Stock's market cap is currently 14.92M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume51.45K
24h highest0.67200 USD
24h lowest0.63800 USD
24h Price movement+0.57%
Start trade with LEXX Perpetual
Sign up to trade